Journal of Stroke & Cerebrovascular Diseases
Volume 19, Issue 4 , Pages 261-268, July 2010

Interactive Effects of Apolipoprotein E Type 4 Genotype and Cerebrovascular Risk on Neuropsychological Performance and Structural Brain Changes

  • David Zade, PhD

      Affiliations

    • Department of Veterans Affairs Boston Medical Center, Geriatric Research Education and Clinical Center, Framingham, Massachusetts
    • Department of Psychiatry, Harvard University Medical School
    • Corresponding Author InformationAddress correspondence to David Zade, PhD, Department of Veterans Affairs Boston Medical Center, Geriatric Research Education and Clinical Center, Department of Psychiatry, Harvard Medical School, 150 S Huntington Ave, D-11-132, Boston, MA 02130.
  • ,
  • Alexa Beiser, PhD

      Affiliations

    • National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts
    • Department of Biostatistics, Boston University School of Medicine
  • ,
  • Regina McGlinchey, PhD

      Affiliations

    • Department of Veterans Affairs Boston Medical Center, Geriatric Research Education and Clinical Center, Framingham, Massachusetts
    • Department of Psychiatry, Harvard University Medical School
  • ,
  • Rhoda Au, PhD

      Affiliations

    • National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts
    • Department of Neurology, Boston University School of Medicine
  • ,
  • Sudha Seshadri, MD

      Affiliations

    • National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts
    • Department of Neurology, Boston University School of Medicine
  • ,
  • Carole Palumbo, PhD

      Affiliations

    • National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts
    • Department of Neurology, Boston University School of Medicine
  • ,
  • Philip A. Wolf, MD

      Affiliations

    • National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts
    • Department of Neurology, Boston University School of Medicine
  • ,
  • Charles DeCarli, MD

      Affiliations

    • University of California, Davis
  • ,
  • William Milberg, PhD

      Affiliations

    • Department of Veterans Affairs Boston Medical Center, Geriatric Research Education and Clinical Center, Framingham, Massachusetts
    • Department of Psychiatry, Harvard University Medical School

Received 2 February 2009; received in revised form 8 May 2009; accepted 18 May 2009. published online 17 May 2010.

Objective

We sought to determine whether the presence of the apolipoprotein E type 4 (apoE4) allele, a known risk factor for Alzheimer disease, interacts with cerebrovascular risk factors to produce a disproportionate impairment in neuropsychological (NP) performance and alterations in structural morphometry as measured by magnetic resonance imaging (MRI).

Methods

In all, 1995 participants from the community-based Framingham Offspring Cohort participants (mean age 61 years; 1063 women) underwent NP testing and structural MRI in 1999 to 2002. Multivariate linear regression was used to estimate the relationships among Framingham Stroke Risk Profile scores, NP variables, and MRI measures; interaction terms were included to examine modification of these relationships by the presence of the apoE4 allele. All analyses were cross sectional.

Results

We found significant interactions between the presence of the apoE4 allele and the top sex-specific quartile of the stroke risk profile and their effects on verbal memory (P ≤ .001), verbal organization (P ≤ .001), nonverbal memory (P=.015), as well as set shifting and complex attention (P=.005). Systolic blood pressure (SBP) was the only individual risk factor significantly linked to these cognitive measures. With the exception of lateral ventricular volume, there were no significant interactions among presence of apoE4, the top sex-specific quartile of the stroke risk profile, and any of the MRI variables.

Conclusion

The apoE4 allele exacerbates the effects of cerebrovascular risk factors on NP function. This relationship appears to be driven by SBP, suggesting that treatment of high SBP could potentially reduce risk of cognitive impairment among those already at increased risk for Alzheimer disease.

Key Words: Apolipoprotein E type 4, cerebrovascular disease, Alzheimer, diabetes, neuropsychology, cognition, magnetic resonance imaging

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the National Heart, Lung, and Blood Institute (NHLBI) Framingham Heart Study (National Institutes of Health/NHLBI Contract N01-HC-25195 PAW) and grants from the National Institute of Neurological Disorders and Stroke (5R01-NS17950 PAW), the National Institute of Aging (5R01-AG08122 PAW, 5R01-AG16495 PAW, 3R01-AG09029), and the Department of Veterans Affairs Merit Review Awards (Drs McGlinchey and Milberg).

PII: S1052-3057(09)00111-6

doi:10.1016/j.jstrokecerebrovasdis.2009.05.001

Journal of Stroke & Cerebrovascular Diseases
Volume 19, Issue 4 , Pages 261-268, July 2010